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Abstract
Background/aims: Intracranial tumours demonstrate characteristic diagnostic histopathological features. Our aims were to 
look at the histo-pathological pattern of  intracranial tumours in our environment including their age and sex distribution.
Methods: The histology request forms and slides of  all intracranial specimens submitted to the histo-pathology department of  
National Hospital, Abuja, over an 11 year period (2005 and 2015) were retrospectively reviewed.
Results: Intracranial specimens and intracranial tumours accounted for 0.6% and 0.5% respectively of  all samples submitted. 
Meningiomas accounted for the most frequent diagnosis for all intracranial specimens and intracranial tumours at 35% and 41% 
respectively followed by pituitary adenoma at 19% and 22%, and astrocytoma at 13% and 20%. The male female ratio for all 
diagnoses was 1:1. The mean age at diagnosis was 35 ± 17.1 years. The frequency of  intracranial tumours in children was 11.8% 
with a mean age of  8.3 ± 4.4 years and an equal sex distribution. In children, glioma and embryonal tumours were the most 
frequent diagnosis at 25%.
Conclusion: The histo-pathological pattern of  intracranial tumours in our environment showed that meningioma is the most 
common intracranial tumour in adults, while glioma and embryonal tumours are the most common intracranial tumours in 
children.
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Introduction
Intracranial tumours may arise from neural tissue within 
the brain as primary tumours or they may be due to me-
tastases. They represent some of  the most biologically ag-
gressive tumours in both adult and paediatric age groups. 
Brain tumours have traditionally been classified based on 
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their presumed cell of  origin and degree of  differentiation 
as determined by light microscopy. However, it is known 
that these tumours have heterogeneous molecular pro-
files, giving rise to varying biological outcomes and hence 
treatment protocols. According to GLOBOCON 2012: 
Estimated cancer incidence, mortality and prevalence 
worldwide, the incidence of  brain tumours was 1.9% 
(equal incidence of  1.8% in both males and females) and 
mortality was 2.3%.1 The types of  tumours seen in adults 
and children differ. Data on the frequency, sub-types and 
clinico-pathologic characteristics of  intracranial tumours 
in Nigeria and Africa is limited. A few studies have been 
done in Nigeria with varying results. The Histo-patholo-
gy Department of  the National Hospital, Abuja, is one 
of  our major neuro-pathological centres in Nigeria and 
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therefore receives specimens from neurosurgery centres 
outside Abuja. This is the first review of  intracranial tu-
mours submitted to the department, and our aims were to 
look at the histo-pathological pattern of  these tumours in 
our environment, increase awareness on their prevalence 
in our environment including their age and sex distribu-
tion. A proper understanding of  the histologic type and 
its epidemiologic variable are important in the manage-
ment of  the patient with intracranial tumour.
Materials and methods
This was a retrospective data based study of  all the intra-
cranial tumours diagnosed in the Department of  Histo-
pathology, National hospital, Abuja, Nigeria between Jan 
2005 and Dec 2015 spanning a period of  11 years. The 
histology request forms and slides of  all intracranial spec-
imens submitted to the Histo-pathology Department of  
National Hospital, Abuja, were retrieved and reviewed. It 
is worth noting that National Hospital, Abuja, has a state-
of-the-art stainless steel tissue and slide cabinet, hence 
blocks from the inception of  the hospital in 1999 are still 
intact. The hospital commenced immunohistochemistry 
analyses of  specimens in 2006, hence specimens from 
2006 were subjected to immunohistochemistry.Data ob-
tained were analyzed using Microsoft® Excel® for Mac 
2011 (version 14.6.3). The cases were classified using 
2007 WHO classification of  intracranial tumours. Con-
fidentiality of  the identity of  the patient and personal 
health information were maintained in strict compliance 
to the Guideline of  Helsinki Declaration on Biomedical 
Research on Human Subject. The limitation of  the study 
is the small number of  the sample compared to the pop-
ulation of  Nigeria which is over 170 million.
Results
A total of  121 intracranial specimens out of  a total of  
20,191 samples were submitted to the Histo-pathology 
Department, National Hospital, Abuja, over an 11-year 
period (2005 and 2015).  These accounted for 0.6% of  
the total specimen received during that period. As shown 
in figure 1, there was an increase in the number of  speci-
mens over the years with the highest number of  samples 
received in 2014 at 28% (n=34) followed by 2015 at 20% 
(n=25) and the year with the lowest recorded samples re-
ceived was 2008 at 0.8% (n=1).
 
 
Figure 1: Chart showing the frequency of intracranial specimens received over 11 years 
Meningiomas accounted for the most frequent diagnosis 
for all intracranial specimens (neoplastic and non-neo-
plastic) at 35% followed by pituitary adenoma 19% and 
astrocytoma at 13%. There were 102 intracranial neo-
plasms (benign and malignant), accounting for 0.5% of  
all samples. Again, Meningioma was the most frequent 
diagnosis at 41%, followed by pituitary adenoma at 22% 
and glioma at 20% (figure 2). The least diagnoses were 
central neurocytoma and ependymoma and at 1% each. 
The male female ratio for all diagnoses was 1:1. 
African Health Sciences Vol 18 Issue 2, June, 2018282
 
 
Figure 2: Chart showing the frequency of intracranial tumours 
The mean age at diagnosis was 35 ± 17.1 years and as 
shown in figure 3, tumours were observed more in pa-
tients in their 30s and 40s. The majority of  the tumours 
were seen in adults at 83.3% with an age range between 
17-74 years and a mean age of  41 ± 12.5 years. The most 
common tumour in adults was meningioma followed by 
pituitary adenoma and glioma. The frequency of  intra-
cranial tumours in children was 11.8% with an age range 
of  between 1-15 years, a mean of  8.3 ± 4.4 years and an 
equal sex distribution. In children, glioma and embryonal 
tumours (medulloblastoma and ependymoma) were the 
most frequent diagnosis at 25% followed by meningioma 
and tumours of  the pineal gland at 16.7% each.
 
 
Figure 3: Chart showing the frequencies of intracranial tumours in the age groups 
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In meningioma, the male female ratio was 1:1, the age 
range was between 9-74 years and the mean age at diag-
nosis was 42.5 ± 12.8 years (table 1). Majority (95.1%) 
were seen in adults while 4.9% were seen in children. The 
most frequently diagnosed sub-type was meningothelial 
meningioma. Pituitary adenomas were the second most 
common tumours accounting for 22% of  cases. There 
was a male predominance (male female ratio = 2:1) and 
a mean age of  44 ± 7 years. Gliomas accounted for the 
third most common tumour. It had a slight female pre-
ponderance (male female ratio = 1:1.7) and the mean age 
at diagnosis was 32 ± 18 years. The frequency of  gliomas 
seen in children was 12.5%. Metastatic adenocarcinomas 
accounted for 4% of  the diagnoses and all the cases were 
seen in adults. All the tumours of  the pineal gland were 
diagnosed in children with a mean age of  6 years and all 
were seen in males. Only one ependymoma was seen and 
it was diagnosed in an 8 year old boy. There was an equal 
distribution of  the medulloblastoma cases as 50% were 
seen in adults and the remaining half  in children. It had 
an equal sex distribution (male female ratio = 1:1) and a 
mean age of  15.5 ± 7.8 years. Cases of  melanoma were 
diagnosed in adults with a mean age of  47 ± 7.1 years and 
all occurred in males.
Table 1: Table showing the sex and age distribution of intracranial  
tumours in both adults and children 
 
Diagnosis Male female ratio Age range (years) Average age (years) 
Meningioma 1:1 9-74 42.5 
Pituitary adenoma 2:1 7-64 44 
Glioma 1:1.7 7-65 32 
PNET 0:2 2-35 18.5 
Metastatic adenocarcinoma 1:1 35-67 53 
Tumours of the pineal gland 2:0 6-13 6 
Ependymoma 1:0   8 
Central neurocytoma 0:1   18 
Medulloblastoma 1:1 1-27 15.5 




Not much research has been done on the histopatholog-
ical pattern of  intracranial tumours in Nigeria. This may 
be due to the limited availability of  diagnostic facilities 
and lack of  presentation of  patients to hospital. It could 
also be due to the inadequate number of  neurosurgeons 
in the country and hence surgical specimens available for 
diagnosis. In our centre, there was a progressive increase 
in the number of  intracranial specimens submitted over 
the years, with a marked increase observed from 2010 on-
wards. This may have coincided with the presence of  ad-
ditional neurosurgeons employed by the hospital includ-
ing the utilization of  our Histo-pathology Department by 
other neurosurgeons in Nigeria with the increased aware-
ness of  the availability of  immunohistochemistry in our 
department.
The relative frequency of  intracranial tumours (0.5%) 
among all specimens submitted over the study period is 
higher than that obtained by Soyemi et al2 (0.004%) in 
a study from South-West Nigeria. However, it contrasts 
with the findings in the study by Awodele et al3 in South-
West Nigeria in which brain cancer represented 3.9% of  
all cancers, and was the 6th most common tumour. In 
other reports, according to the National Cancer Regis-
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try of  South Africa, brain tumours accounted for 0.56% 
of  all cancers in males and 0.36% in females.4 In Ghana, 
CNS tumours represented 0.31% of  all hospital admis-
sions and 22% of  neurosurgical procedures.5 A review of  
the hospital and death registers of  the Lagos University 
Teaching Hospital, Nigeria, showed that CNS-associated 
cancer was responsible for 4.9% of  all deaths.6
There was equal gender distribution (male female ratio 
= 1:1) seen in our study. This is similar to that report-
ed by Olasode et al7 and Soyemi et al2 but in contrast to 
the slight male dominance observed by Idowu et al8, both 
studies from South-West Nigeria. The mean age in adults 
was 41 years with more tumours seen in the 4th and 5th 
decades. This is in contrast to studies seen in other parts 
of  the country, which showed age range between 33-50 
years.8-10 The mean age for children was 8 years and this is 
similar to that reported by Idowu et al.8
In this study meningiomas accounted for the most fre-
quent diagnosis for all intracranial tumours at 41% fol-
lowed by pituitary adenomas 22% and gliomas at 20%. 
The high prevalence of  meningiomas in our study com-
pares with the findings by Idowu et al8, Ibebuike et al11 in 
Johannesburg, South Africa, which both reported menin-
giomas as the most common brain tumour in their stud-
ies. However, it contrasts with other studies showing glio-
mas to be the most common intracranial tumour.2,7,10 The 
equal male female ratio of  1:1 for meninigiomas in our 
study agrees with earlier observations in the literature12,13, 
which reported equal gender distribution, but contrasts 
with studies by Idowu et al8 and Ibebuike et al11, which 
revealed female preponderance. However, Fynn et al14 
in Pretoria, South Africa (2.5:1) and Gasparetto et al15 in 
Brazil reported a male preponderance in their study (2:1).
Pituitary adenomas had a frequency of  22% and were 
seen more in males. Olasode et al7 and Idowu et al8 re-
ported a frequency of  17.1% and 16% in their studies. 
Gliomas, which have been reported as the most frequent-
ly observed brain tumours in some studies, was the third 
commonest in our study at 20%.  In our study, the mean 
age for children was 8.3 years, and this was slightly higher 
than the 7.3 years reported by Ogun et al16 but similar to 
that reported by Ahmed et al17 in Pakistan of  8.8 years. 
Gliomas and embryonal tumours (medulloblastoma and 
ependymoma) were the most common tumours seen in 
children. This contrasts with studies showing gliomas to 
be more common in children.7,16,18,19
There are known risk factors associated with brain tu-
mors and these include radiation exposure, hereditary 
factors, age, sex, ethnicity, infections, and heavy metal 
exposure.20 Not many studies have been carried out in 
our environment to elucidate possible risk factors for de-
velopment of  intracranial tumours. However, high levels 
of  lead have been associated with development of  me-
ningiomas. It has been suggested that ingestion of  snails, 
canned meat and fish may be risk factors for develop-
ment of  meningiomas.20
Conclusion
Our findings indicate that meningioma is the most com-
mon intracranial tumour in adults, while glioma and 
embryonal tumours are the most common intracranial 
tumour in children in our environment. The histopatho-
logical pattern of  intracranial tumours in our environ-
ment provides significant information on the behavior of  
these tumours. However, inadequate facilities, dearth of  
neurosurgeons and resources hamper research. Addition-
ally, genetic researches need to be carried out as they may 
provide greater understanding of  CNS tumours.
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